(Q34105472)

31 July 2017

1 reference

title

Nitric oxide and postangioplasty restenosis: pathological correlates and therapeutic potential (English)

1 reference

31 July 2017

Janero DR

1

1 reference

31 July 2017

Ewing JF

series ordinal

2

1 reference

31 July 2017

publication date

1 December 2000

1 reference

Free Radical Biology and Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

29

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

1199-1221

1 reference

Cardiovascular specialty societies and the emerging global burden of cardiovascular disease: a call to action

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Primary prevention of coronary heart disease: integrating risk assessment with intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Acute occlusion after percutaneous transluminal coronary angioplasty--a new approach

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The pathogenesis of atherosclerosis (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Therapeutic potential of vitamin E in the pathogenesis of spontaneous atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Coronary risk factors, endothelial function, and atherosclerosis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Myocardial ischemia--metabolic pathways and implications of increased glycolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Ischemic heart disease and antioxidants: mechanistic aspects of oxidative injury and its prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction: results from the global use of strategies to open occluded arteries in Acute Coronary Syndromes (GUSTO-IIb)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Thrombolysis for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Beyond stents: third-generation coronary devices

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Procedural results and late clinical outcomes after placement of three or more stents in single coronary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The biology of restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Prevention of coronary restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Pathology of transluminal balloon angioplasty used in the treatment of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Relation to restenosis after percutaneous transluminal coronary angioplasty to vasomotion of the dilated coronary arterial segment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Histopathologic phenomena at the site of percutaneous transluminal coronary angioplasty: the problem of restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effects of percutaneous transluminal coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Pharmacological approaches for the prevention of restenosis after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Restenosis: Animal models and morphometric techniques in studies of the vascular response to injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Clinical trials to prevent restenosis after percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Prolonged thrombin inhibition reduces restenosis after balloon angioplasty in porcine coronary arteries.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Why do animal models of post-angioplasty restenosis sometimes poorly predict the outcome of clinical trials?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Platelets and restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Intracoronary stenting. From concept to custom

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

In vivo assessment of stent expansion and recoil in normal porcine coronary arteries: differential outcome by stent design

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Balloon-artery interactions during stent placement: a finite element analysis approach to pressure, compliance, and stent design as contributors to vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Three-year follow-up after implantation of metallic coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Long-term clinical follow-up after successful repeat percutaneous intervention for stent restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Six-month angiographic outcome after successful repeat percutaneous intervention for in-stent restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Coronary atherosclerosis and interventions: pathological sequences and restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Biocompatibility aspects of new stent technology

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Stent-versus-stent equivalency trials : are some stents more equal than others?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Reactivity of nitrogen monoxide species with NADH: implications for nitric oxide-dependent posttranslational protein modification

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Biosynthesis and action of nitric oxide in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Pathophysiological chemistry of nitric oxide and its oxygenation by-products.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Specific S-nitrosothiol (thionitrite) quantification as solution nitrite after vanadium(III) reduction and ozone-chemiluminescent detection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Chemical biology of nitric oxide: Insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nitric oxide (NO)-related pharmaceuticals: contemporary approaches to therapeutic NO modulation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Role of NO in vascular smooth muscle and cardiac muscle function

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Catalysis by nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

L-arginine improves endothelium-dependent vasorelaxation and reduces intimal hyperplasia after balloon angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Cyclic AMP-adenosine pathway induces nitric oxide synthesis in aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nitric oxide in cardiovascular disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Impaired endothelial regulation of vascular tone in patients with systemic arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Adhesion and signaling in vascular cell--cell interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nitric oxide released from activated platelets inhibits platelet recruitment

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Analysis of lysophophatidylcholine-induced endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The vascular biology of nitric oxide and its role in atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nitric oxide inhibition of endothelial cell mitogenesis and proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Natural course of the impairment of endothelium-dependent relaxations after balloon endothelium removal in porcine coronary arteries. Possible dysfunction of a pertussis toxin-sensitive G protein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Balloon angioplasty and induction of non-endothelial nitric oxide synthase in rabbit carotid arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Overexpression of inducible nitric oxide synthase by neointimal smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Regulation of inducible nitric oxide synthase gene expression in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The use of inhaled nitric oxide in a wide variety of clinical problems

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Inhaled nitric oxide increases coronary artery patency after thrombolysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Control of coronary vascular tone by nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Ultrastructural Changes of the Rabbit Lung after a 5 ppm Nitric Oxide Exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Respiratory effect of 2-hr exposure to 1.0 ppm nitric oxide in normal subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

L-arginine augments endothelium-dependent vasodilation in cholesterol-fed rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Dietary l-arginine decreases myointimal cell proliferation and vascular monocyte accumulation in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Discordant effects of dietary L-arginine on vascular structure and reactivity in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effects of infusion of L-arginine into the left anterior descending coronary artery on acetylcholine-induced vasoconstriction of human atheromatous coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effects of in vivo and in vitro L-arginine supplementation on healthy human vessels.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Regression or progression. Dependency on vascular nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Dietary l -Arginine Reduces the Progression of Atherosclerosis in Cholesterol-Fed Rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

L-arginine inhibits balloon catheter-induced intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

L-arginine inhibits neointimal formation following balloon injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Continuous perivascular L-arginine delivery increases total vessel area and reduces neointimal thickening after experimental balloon dilatation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Role of nitric oxide in restenosis after experimental balloon angioplasty in the hypercholesterolemic rabbit: effects on neointimal hyperplasia and vascular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The effects of L-arginine on neointimal formation and vascular function following balloon injury in heritable hyperlipidaemic rabbits.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The vascular effects of L-Arginine in humans. The role of endogenous insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Insulin stimulates both endothelin and nitric oxide activity in the human forearm.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Hypercholesterolemia increases endothelial superoxide anion production

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Analysis of substrate-induced electronic, catalytic, and structural changes in inducible NO synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Differential regulation of L-arginine transport and nitric oxide production by vascular smooth muscle and endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Does acute improvement of endothelial dysfunction in coronary artery disease improve myocardial ischemia? A double-blind comparison of parenteral D- and L-arginine.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Troglitazone upregulates nitric oxide synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Functionally thrombasthenic state in normal platelets following the administration of ticlopidine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effect of cilostazol, a cAMP phosphodiesterase inhibitor, on nitric oxide production by vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF-kappa B, CREB and C/EBP beta

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Homocysteine increases nitric oxide synthesis in cytokine-stimulated vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Arthur C. Corcoran Memorial Lecture. Hormones and vasoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Estradiol inhibition of arterial neointimal hyperplasia after balloon injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Estrogen inhibits the response-to-injury in a mouse carotid artery model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Conjugated equine estrogens inhibit progression of atherosclerosis but have no effect on intimal hyperplasia or arterial remodeling induced by balloon catheter injury in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Ticlopidine increases nitric oxide generation in heart-transplant recipients: a possible novel property of ticlopidine

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Limitations of angiotensin-converting enzyme inhibitor in restenosis of a deep arterial injury model

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effect of high dose angiotensin-converting enzyme inhibition on restenosis: final results of the MARCATOR Study, a multicenter, double-blind, placebo-controlled trial of cilazapril. The Multicenter American Research Trial With Cilazapril After Angio

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Angiotensin-converting enzyme inhibition with fosinopril sodium in the prevention of restenosis after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effects of pemirolast and tranilast on intimal thickening after arterial injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Tranilast suppresses the vascular intimal hyperplasia after balloon injury in rabbits fed on a high-cholesterol diet

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effectiveness of tranilast on restenosis after directional coronary atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The PRESTO (Prevention of restenosis with tranilast and its outcomes) protocol: a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effect of cilostazol, a novel anti-platelet drug, on restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Impact of cilostazol on intimal proliferation after directional coronary atherectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effects of cilostazol on late lumen loss after Palmaz-Schatz stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Pulsatile Stretch and Shear Stress: Physical Stimuli Determining the Production of Endothelium-Derived Relaxing Factors

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Exercise training increases basal nitric oxide production from the forearm in hypercholesterolemic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Preventive effect of exercise training on recurrent stenosis after percutaneous transluminal coronary angioplasty (PTCA).

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Estrogens, progestins and coronary artery reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Troglitazone inhibits alpha1-adrenoceptor-induced DNA synthesis in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Modulation of adenovirus-mediated gene transfer by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nitric oxide synthase gene transfer to the vessel wall

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Expression and function of a recombinant endothelial nitric oxide synthase gene in porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Gene therapy for restenosis: getting nearer the heart of the matter

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Gene therapy for restenosis: are we ready?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Gene therapy of restenosis: promise and perils

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Gene therapist, heal thyself

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The use of nitric oxide donors in pharmacological studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nitric oxide and nitrovasodilators: similarities, differences and potential interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Potential role of a membrane-bound NADH oxidoreductase in nitric oxide release and arterial relaxation to nitroprusside

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Hypercholesterolemia enhances macrophage recruitment and dysfunction of regenerated endothelium after balloon injury of the rabbit iliac artery

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nitroglycerin decreases medial smooth muscle cell proliferation after arterial balloon injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

FK409, a new nitric-oxide donor, suppresses smooth muscle proliferation in the rat model of balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

A nitric oxide donor (spermine-NONOate) prevents the formation of neointima in rabbit carotid artery

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Use of nitric-oxide-eluting polymer-coated coronary stents for prevention of restenosis in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effect of nitric oxide donors on neointima formation and vascular reactivity in the collared carotid artery of rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Dynamic state of S-nitrosothiols in human plasma and whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty. The ACCORD Study. Angioplastic Coronaire Corvasal Diltiazem

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Pharmacologic effects of calcium channel blockers on restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Alternative therapy bias.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Antisense strategies to inhibit restenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Enhanced release of prostaglandins contributes to flow-induced arteriolar dilation in eNOS knockout mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

VEGF Gene Transfer Reduces Intimal Thickening via Increased Production of Nitric Oxide in Carotid Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Reciprocal relation between VEGF and NO in the regulation of endothelial integrity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

NO-aspirin protects from T cell–mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Role of inducible nitric oxide synthase in transplant arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

The mechanisms of coronary restenosis: insights from experimental models

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Animal models for atherosclerosis, restenosis, and endovascular graft research

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Arterial remodeling. Mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Cell cycle molecules and diseases of the cardiovascular system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Restenosis: a challenge for pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Prevention of coronary restenosis : the evolving evidence base for radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Inhibition of restenosis with beta-emitting radiotherapy: Report of the Proliferation Reduction with Vascular Energy Trial (PREVENT)

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Influence of postangioplasty beta-irradiation on endothelial function in porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

What we know and don't know about L-arginine and NO

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Effects of L-arginine on vascular smooth muscle cell proliferation and apoptosis after balloon injury

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Cell-Surface Estrogen Receptors Mediate Calcium-Dependent Nitric Oxide Release in Human Endothelia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

Bradykinin B(1) receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2800%2900434-2

7 January 2021

10.1016/S0891-5849(00)00434-2

Identifiers

DOI

1 reference

31 July 2017

1 reference